Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 3/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL559602 | 1.00 | PTGS2 (0.36) | PTGS2KCNH2GPR35CYP3A4ALDH1A1 | |
| SCHEMBL2367919 | 1.00 | PTGS2 (0.36) | PTGS2KCNH2GPR35CYP3A4ALDH1A1 | |
| SCHEMBL2496088 | 0.96 | PTGS2 (0.38) | PTGS2KCNH2GPR35CYP3A4ALDH1A1 | |
| SCHEMBL2469032 | 0.96 | PTGS2 (0.38) | PTGS2KCNH2GPR35CYP3A4ALDH1A1 | |
| SCHEMBL13299960 | 0.96 | PTGS2 (0.38) | PTGS2KCNH2GPR35CYP3A4ALDH1A1 | |
| SCHEMBL17970826 | 0.93 | PTGS2 (0.33) | PTGS2KCNH2GPR35MAPT | |
| SCHEMBL18643477 | 0.92 | PTGS2 (0.32) | PTGS2KCNH2GPR35MAPT | |
| SCHEMBL17970676 | 0.89 | GPR35 (0.32) | PTGS2KCNH2GPR35MAPT | |
| SCHEMBL18435064 | 0.87 | — | — | |
| SCHEMBL17970822 | 0.87 | HDAC3 (0.38) | PTGS2CYP3A4ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8816100-B2 | Compound, method of producing the compound, organic semiconductor material and organic semiconductor device | HIROSHIMA UNIVERSITY (JP) | 2014-08-26 | — | — | US | disclosed |
| US-20140051865-A1 | DESCRIPTION NOVEL COMPUND, METHOD OF PRODUCING THE COMPOUND, ORGANIC SEMICONDUCTOR MATERIAL AND ORGANIC SEMICONDUCTOR DEVICE | HIROSHIMA UNIVERSITY (JP) | 2014-02-20 | — | — | US | disclosed |
| US-20110224445-A1 | Novel Compound, Method of Producing the Compound, Organic Semiconductor Material and Organic Semiconductor Device | HIROSHIMA UNIVERSITY (JP) | 2011-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110224445-A1 | Novel Compound, Method of Producing the Compound, Organic Semiconductor Material and Organic Semiconductor Device | TST, SCLY, SELENOI | PTGS2 2702/4885KCNH2 782/4885GPR35 3640/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.